Nuvilex, Inc. (OTC Bulletin Board: NVLX), announces today that Legacy Biotechnologies, Inc., its joint venture partner in Reme-Flu™ homeopathic flu remedy, has reached an agreement with Phillips Sales and Marketing to begin the national sales and marketing campaign for retail distribution of Reme-Flu™.
“We are pleased that retail distribution is about to commence on Reme-Flu™ and anticipate this year-round product will attain its own market niche with consistent annual sales growth”
Phillips Sales and Marketing has been involved with both the sales and marketing of nutriceutical and cosmeceutical products in the mass market for over 20 years. They also specialize in working with small and medium size regional drugstore chains. Phillips has run several successful sales and marketing campaigns and has been able to take products from introduction into the market all the way to distribution on a national level. Through unique advertising methods, Phillips has created product demand that resulted in product placement and sales in major drug chains, some of which are comprised of several thousand stores. Legacy Biotechnologies’ goal is to have attained distribution on a national level within 9-12 months.
“We are pleased that retail distribution is about to commence on Reme-Flu™ and anticipate this year-round product will attain its own market niche with consistent annual sales growth,” stated Martin Schmieg, Chairman and CEO of Nuvilex, Inc.
Electronic nudges improve flu vaccination rates in non-diabetic patients but fail to increase uptake in diabetics